ArticleFrontiers in toxicology2026
Combined exposure to emerging
Article in Frontiers in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Beauvericin (BEA), enniatin B (ENN B), and moniliformin (MON), mainly produced by Fusarium species, are often described as emerging mycotoxins due to their frequent detection in cereals and cereal-based products and their current lack of regulatory limits. Despite increasing evidence regarding their individual toxicities-including immunotoxic, genotoxic, reproductive, and cardiotoxic effects-information on their combined toxicity and the underlying mechanisms remains limited. To address this gap, this study aimed to evaluate the cytotoxic effects, reactive oxygen species (ROS) generation, and interaction patterns of BEA, ENN B, and MON in human Jurkat T cells following a 24-hour exposure under individual, dual, and triple treatment conditions. Methods: The experimental approach evaluated cellular responses and toxicological interactions across single and combined exposures. Cytotoxicity was assessed using the MTT assay to determine cell viability, while intracellular ROS levels were measured using a fluorescence-based assay. To analyze the dual and mixture interaction patterns among the mycotoxins, the study utilized the Chou-Talalay method for quantitative assessment of synergism and antagonism. Results: The individual toxicity assessments yielded IC Discussion: Overall, these findings demonstrate that co-exposure to BEA, ENN B, and MON leads to complex interactive toxicities, with the ternary mixture showing persistent synergistic effects based on Combination Index analysis. Although these cellular responses strongly correlate with elevated ROS-associated fluorescence signals, direct experimental validation is still required to confirm the specific downstream molecular mechanisms involved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.